147 related articles for article (PubMed ID: 37852019)
1. Efficacy and tolerability of oxcarbazepine in the treatment of focal epilepsy in neonates and infants under 3 months of age: A single-center retrospective analysis.
Ma Y; Deng J; Fu Z; Chen C; Wang X; Wang X; Weng J; Shen Y; Wang X; Fang F
Epilepsy Res; 2023 Nov; 197():107240. PubMed ID: 37852019
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of the efficacy and influencing factors of sodium channel blockers in the treatment of focal epilepsy in infants under 6 months of age].
Ma YP; Deng J; Fu ZR; Chen CH; Wang XH; Wang X; Weng JW; Shen YH
Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):983-988. PubMed ID: 37899337
[No Abstract] [Full Text] [Related]
3. A comparison of the efficacy and tolerability of oxcarbazepine oral suspension between infants and children with epilepsy: a retrospective chart review at a single medical center in Taiwan.
Wei SH; Liu CC; Fan PC
Paediatr Drugs; 2014 Feb; 16(1):83-9. PubMed ID: 24081427
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
[TBL] [Abstract][Full Text] [Related]
5. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
[TBL] [Abstract][Full Text] [Related]
6. Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Berghuis B; Hulst J; Sonsma A; McCormack M; de Haan GJ; Sander JW; Lindhout D; Koeleman BPC
Epilepsia; 2021 Mar; 62(3):778-784. PubMed ID: 33576502
[TBL] [Abstract][Full Text] [Related]
7. Prospective study on long-term treatment with oxcarbazepine in pediatric epilepsy.
Franzoni E; Gentile V; Pellicciari A; Garone C; Iero L; Gualandi S; Cordelli DM; Cecconi I; Moscano FC; Marchiani V; Errani A
J Neurol; 2009 Sep; 256(9):1527-32. PubMed ID: 19597919
[TBL] [Abstract][Full Text] [Related]
8. [Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study].
Steinhoff BJ; Stefan H; Schulze-Bonhage A; Hueber R; Paulus W; Wangemann M; Elger CE
Nervenarzt; 2012 Oct; 83(10):1292-9. PubMed ID: 22850688
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study.
Zhao B; Liao S; Zhong X; Luo Y; Hong S; Cheng M; Zhang J; Li T; Jiang L
Front Neurol; 2022; 13():909191. PubMed ID: 35720076
[TBL] [Abstract][Full Text] [Related]
10. Sustained efficacy and long-term safety of oxcarbazepine: one-year open-label extension of a study in refractory partial epilepsy.
Beydoun A; Sachdeo RC; Kutluay E; McCague K; D'Souza J
Epilepsia; 2003 Sep; 44(9):1160-5. PubMed ID: 12919387
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.
Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D
Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847
[TBL] [Abstract][Full Text] [Related]
12. [Oxcarbazepine in the treatment of epilepsy].
Freidel M; Krause E; Kuhn K; Peper R; Vogel H
Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
[TBL] [Abstract][Full Text] [Related]
13. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy.
Dogan EA; Usta BE; Bilgen R; Senol Y; Aktekin B
Epilepsy Behav; 2008 Jul; 13(1):156-61. PubMed ID: 18331816
[TBL] [Abstract][Full Text] [Related]
16. Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.
Mäkinen J; Rainesalo S; Peltola J
Brain Behav; 2017 Mar; 7(3):e00634. PubMed ID: 28293474
[TBL] [Abstract][Full Text] [Related]
17. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy.
Guerreiro MM; Vigonius U; Pohlmann H; de Manreza ML; Fejerman N; Antoniuk SA; Moore A
Epilepsy Res; 1997 Jun; 27(3):205-13. PubMed ID: 9237055
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomics of oxcarbazepine in the treatment of epilepsy.
Yuan Y; Zhang S; Yuan Y; Yan X; Zhang L; Ran YW
Pharmacogenomics; 2023 Apr; 24(6):335-343. PubMed ID: 37092337
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Berghuis B; van der Palen J; de Haan GJ; Lindhout D; Koeleman BPC; Sander JW;
Epilepsia; 2017 Jul; 58(7):1227-1233. PubMed ID: 28542738
[TBL] [Abstract][Full Text] [Related]
20. Prescribed antiseizure medication doses and their relation to defined daily doses for achieving seizure freedom in newly diagnosed patients with epilepsy.
Hersi H; Raitanen J; Saarinen JT; Peltola J
Epilepsia Open; 2023 Sep; 8(3):811-819. PubMed ID: 37010264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
